BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30156536)

  • 1. One year in review 2018: Sjögren's syndrome.
    Argyropoulou OD; Valentini E; Ferro F; Leone MC; Cafaro G; Bartoloni E; Baldini C
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):14-26. PubMed ID: 30156536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Sjögren's syndrome and deficiency of ICA69.
    Winer S; Astsaturov I; Cheung R; Tsui H; Song A; Gaedigk R; Winer D; Sampson A; McKerlie C; Bookman A; Dosch HM
    Lancet; 2002 Oct; 360(9339):1063-9. PubMed ID: 12383988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highlights of the 14th International Symposium in Sjögren's Syndrome.
    Bombardieri M; Baldini C; Alevizos I; Akpek E; Baer AN
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):3-13. PubMed ID: 30156541
    [No Abstract]   [Full Text] [Related]  

  • 4. One year in review 2017: primary Sjögren's syndrome.
    Ferro F; Marcucci E; Orlandi M; Baldini C; Bartoloni-Bocci E
    Clin Exp Rheumatol; 2017; 35(2):179-191. PubMed ID: 28337967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One year in review 2020: pathogenesis of primary Sjögren's syndrome.
    Bombardieri M; Argyropoulou OD; Ferro F; Coleby R; Pontarini E; Governato G; Lucchesi D; Fulvio G; Tzioufas AG; Baldini C
    Clin Exp Rheumatol; 2020; 38 Suppl 126(4):3-9. PubMed ID: 33025887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of histopathological examination of salivary gland biopsies in diagnosis, prognosis and treatment of Sjögren's Syndrome.
    Barone F; Campos J; Bowman S; Fisher BA
    Swiss Med Wkly; 2015; 145():w14168. PubMed ID: 26375728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sjögren's syndrome in the elderly].
    Gentric-Tilly A
    Ann Med Interne (Paris); 2002 Oct; 153(6):378-82. PubMed ID: 12486386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immune factors involved in the pathogenesis, diagnosis, and treatment of Sjogren's syndrome.
    Huang YF; Cheng Q; Jiang CM; An S; Xiao L; Gou YC; Yu WJ; Lei L; Chen QM; Wang Y; Wang J
    Clin Dev Immunol; 2013; 2013():160491. PubMed ID: 23935646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One year in review 2019: Sjögren's syndrome.
    Cafaro G; Croia C; Argyropoulou OD; Leone MC; Orlandi M; Finamore F; Cecchettini A; Ferro F; Baldini C; Bartoloni E
    Clin Exp Rheumatol; 2019; 37 Suppl 118(3):3-15. PubMed ID: 31464675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the type I interferon pathway in primary Sjögren's syndrome: an update.
    Vakaloglou KM; Mavragani CP
    Curr Opin Rheumatol; 2011 Sep; 23(5):459-64. PubMed ID: 21760509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sjögren's syndrome: one year in review 2022.
    Manfrè V; Chatzis LG; Cafaro G; Fonzetti S; Calvacchi S; Fulvio G; Navarro Garcia IC; La Rocca G; Ferro F; Perricone C; Bartoloni E; Baldini C
    Clin Exp Rheumatol; 2022 Dec; 40(12):2211-2224. PubMed ID: 36541236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One year in review 2015: Sjögren's syndrome.
    Luciano N; Valentini V; Calabrò A; Elefante E; Vitale A; Baldini C; Bartoloni E
    Clin Exp Rheumatol; 2015; 33(2):259-71. PubMed ID: 25896475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to assess treatment efficacy in Sjögren's syndrome?
    Vissink A; Bootsma H; Kroese FG; Kallenberg CG
    Curr Opin Rheumatol; 2012 May; 24(3):281-9. PubMed ID: 22450393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial neural networks help to identify disease subsets and to predict lymphoma in primary Sjögren's syndrome.
    Baldini C; Ferro F; Luciano N; Bombardieri S; Grossi E
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):137-144. PubMed ID: 30156549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sjögren's syndrome: where do we stand, and where shall we go?
    Cornec D; Jamin C; Pers JO
    J Autoimmun; 2014 Jun; 51():109-14. PubMed ID: 24612946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sjögren's syndrome: disease activity indexes! Do they make us better clinicians or technicians?
    Moutsopoulos HM; Skopouli FN
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):29-30. PubMed ID: 29846164
    [No Abstract]   [Full Text] [Related]  

  • 17. One year in review 2016: Sjögren's syndrome.
    Ferro F; Vagelli R; Bruni C; Cafaro G; Marcucci E; Bartoloni E; Baldini C
    Clin Exp Rheumatol; 2016; 34(2):161-71. PubMed ID: 27095672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting primary Sjögren's syndrome.
    Odani T; Chiorini JA
    Mod Rheumatol; 2019 Jan; 29(1):70-86. PubMed ID: 30424703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updates on Sjögren's syndrome: from proteomics to protein biomarkers.
    Baldini C; Cecchettini A; Gallo A; Bombardieri S
    Expert Rev Proteomics; 2017 Jun; 14(6):491-498. PubMed ID: 28532233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FcRL4
    Haacke EA; Bootsma H; Spijkervet FKL; Visser A; Vissink A; Kluin PM; Kroese FGM
    J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.